Skip to main content
AKBA logo

AKBA · Akebia Therapeutics, Inc. · Proposed Sales

Track AKBA — free
$0.87 -0.01 (-0.69%) At close · Oct 2
Market Cap
$244.05M
Shares
277.11M
Volume · Oct 2 7.11M Avg daily vol (3M) 6.07M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-06-29 Ostrowski Erik 56,019
2026-02-02 Butler John P. 341,305
2026-02-02 Rucci Carolyn M. 69,772
2026-02-02 Grund Nicholas 84,829
2026-02-02 Burke Steven Keith 67,658
2026-02-02 Ostrowski Erik 34,951
2025-06-30 Ostrowski Erik 41,314
2025-03-03 Burke Steven Keith 7,144
2025-03-03 Butler John P. 46,409
2025-02-03 Butler John P. 144,250
2025-02-03 Grund Nicholas 55,621
2025-02-03 Burke Steven Keith 50,506
2024-05-13 Hadas Nicole R. 12,016
2024-05-13 Dahan Michel 34,840
2024-02-29 Dahan Michel 8,661
2024-02-29 Hadas Nicole R. 5,974
2024-02-29 Butler John P. 46,570
2024-02-29 Burke Steven Keith 7,169
2024-02-27 Hadas Nicole R. 7,411
2024-02-27 Butler John P. 37,733
2024-02-27 Burke Steven Keith 8,367
2024-02-27 Dahan Michel 10,744
2024-02-01 Butler John P. 46,489
2024-02-01 Burke Steven Keith 24,311
2023-05-25 Hadas Nicole R. 63,186
2023-05-25 Dahan Michel 95,478
2023-05-16 Burke Steven Keith 63,567
2023-05-16 Spellman David A 63,567
Showing 1–28 of 28 filings
Key facts CIK 1517022 CUSIP 00972D105 13F (30d) 3 filings 3 filers Visit website Investor relations